Abstract submission

The abstract submission for the ERS International Congress 2017 is now open and will close on Monday 13 February, 2017 at 13:00 CET (EXTENDED DEADLINE). Submit your abstract on myERS.

Abstracts will be published in a supplement of the September 2017 edition of the ERJ. All accepted abstracts will be visible online from 2 September 2017.

The ERS International Congress is a key event in the respiratory calendar. Presenting at the Congress will help you gain international recognition for your work and boost your profile among the world's leading respiratory experts.

How to submit

  • Abstracts can be submitted on 'myERS'.

Information and guidelines for abstract submission

  • General abstract submission is free of charge. However, please note that there is a fee of €75 for submission of late-breaking abstracts. 
  • The data in the abstract must not have been published before the ERS International Congress.
  • All submitted abstracts will be forwarded to the ERS International Congress Programme Committee for their consideration.
  • The acceptance rate for the general round of submission is below 80% and for the late-breaking abstract the acceptance is usually of 50% or less.
  • Access the full guidelines for abstract submission

All submitted abstracts are reviewed anonymously based on scientific strength, methodology and the data provided, in addition to the novelty and originality of the findings.

Make sure your abstract is finalised as it cannot be modified after the submission deadline. ERS suggests that you ask your peers to proofread it to ensure there are no errors. A good abstract is not only based on its content, as the message also needs to be clear and well communicated.

Instructions for online submission and guide on "How to write an abstract"

We are also offering an online educational course to provide expert advice to young researchers who are preparing abstracts and presentations for the ERS International Congress or any other scientific conference. Find out more and register for the 'Prepare Your Congress Contribution' course.

The best abstracts are accepted for the abstract sessions and will be presented as oral presentations, thematic posters and poster discussions.

When submitting an abstract you can also apply for an abstract grant and ERS sponsorship:

Frequently asked questions on abstracts

General

What is an abstract?

An abstract is a summary of a paper (research publication). The study and results reported should be novel and not simply an extension of previously published work.

What is a late-breaking abstract?

Abstracts that are considered as late-breaking must contain novel data and this data must became available for public dissemination only after the standard abstract deadline on 13 February 2017.

The study and results reported should be novel and not simply an extension of previously published work. The late-breaking abstract round is not designed to favour investigators who unintentionally missed the deadline for the regular abstract submission.

My project is still ongoing and there are no results yet, should I still submit an abstract?

Abstracts are intended to present scientific studies and research. If your study is currently ongoing and you only have preliminary data, but it seems relevant or significant, you can submit the abstract. However please be aware that abstracts with incomplete data may have less chance of being accepted for the ERS International Congress.

After your abstract is accepted you cannot update the content of your abstract for the official publication as the accepted version will be published, however you are permitted to present updated information onsite at the Congress.

Can I submit an abstract that has already been presented at different event?

We do not accept abstracts that have already been presented and published. You are permitted to submit something similar at the ERS Congress, however we expect additions / new data to an abstract presented at another congress.

Can I submit a case report study?

We do not encourage to submit the case study abstracts however we accept them if they are well prepared. We do not provide specific templates for this kind of abstracts.

Do I need to disclose information of conflict of interest in my abstract?

Yes; when you are submitting your abstract you will have the opportunity to disclose your conflict of interest. Conflict of interest statement is only required for the first author.

Where can I find the guidelines on how to prepare an abstract?

You can access the instructions from this page or from the submission platform.

What is the required structure for an abstract?

Title: The title should be an accurate description of the abstract's contents. It should explain as much as possible about the context and the aims of the study. The title should be about 10–12 words long, and should include the scope of the investigation, the study design and the goal. The title should be a description of what was investigated rather than a statement of the results or conclusions. The abstract title should be easy for the reader to understand and should not include jargon or unfamiliar acronyms or abbreviations. The title should not be in capital letters.

Authors: The list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.

Main text: A good abstract should address the five following questions in the relevant sections:

1. "Why did you start?" – Introduction or background / You should summarise, preferably in one sentence, the current knowledge specifically in relation to the work you are presenting.

2. "What did you try to do?" – Aims and objectives / State the aim of your study, and ideally include a short statement of the study's hypothesis. A legitimate scientific study is not done "to prove that something is true" but rather "to find out whether it is true." The distinction may seem small but it makes a significant difference. A formal hypothesis shows that you are objective.

3. "What did you do?" – Methods / In an abstract, the description of the methods has to be concise, and much of the details of what was done must be omitted. However, in a few short sentences, you can give the reader a good idea of the design of the study, the context in which it was done, and the types of patients or measurements that were included.

4. "What did you find?" – Results / It is important to give the main results of the study, not in subjective terms ("We found device X to be superior to device Y") but also in the form of some real data. You will need to choose which findings to report here: it should be the most important data in your study, and the findings on which your conclusions will be based. Do not include a table or figure unless you need it to show your results.

5. "What does it mean?" – Conclusions / Here, space constraints generally limit you to a single sentence of why you think your findings are important, and their potential implications. Keep your conclusions reasonable and supportable by the findings of your study. Remember that if your study was restricted to certain patients, or a particular therapy, or a specific device, its results may not extend beyond these restrictions.

Please see the full guidelines for more information

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.

Submission

I missed the deadline for the 1st round of abstract submission. Can I submit my abstract as a late-breaking abstract?

The late-breaking abstract round is not an extension for the regular abstract submission deadline.

When is the submission deadline for abstracts and late-breaking abstracts?

The submission deadline for abstracts was on 13 February, it is now closed.
The submission period for late-breaking abstract is from 1 May to 31 May 2017. Note that the submission is not free, €75 submission fee applies for each late-breaking abstract submission (non-refundable). For people based in Switzerland additionally 8% VAT will apply.

How do I submit a late breaking abstract?

You must submit your late breaking abstract online by logging in to myERS and choosing the 'Abstract' menu, and then select 'Congress submission'. The submission period for late-breaking abstract is from 1 May to 31 May 2017.
Note that the submission is not free, €75 submission fee applies for each late-breaking abstract submission (non-refundable). For people based in Switzerland additionally 8% VAT will apply.

How many abstracts can I submit?

A maximum of three abstracts may be submitted by the same presenting author.

Who has the copyright for my abstract after submission?

Copyright for abstracts is retained by authors (see on submission Terms & Agreement "11. Copyright, if this abstract is accepted, will be held by the author or employer (as part of the conditions of the author(s)'s employment).")
The abstracts are not published under a creative commons framework (Creative Commons licencing is most generally used to 'describe' how you can 'use/re-use' an open access document). The abstracts are not published open access. They are free to access (on both the ERS platforms and when they are published as a supplement of the ERJ), which is different to open access, and are copyright to the author.

What are the different abstract submission categories?

The full list can be found here.

Where can I find the guidelines on how to prepare an abstract?

You can access the instructions from this page or from the submission platform.

What is the required structure for an abstract?

Title: The title should be an accurate description of the abstract's contents. It should explain as much as possible about the context and the aims of the study. The title should be about 10–12 words long, and should include the scope of the investigation, the study design and the goal. The title should be a description of what was investigated rather than a statement of the results or conclusions. The abstract title should be easy for the reader to understand and should not include jargon or unfamiliar acronyms or abbreviations. The title should not be in capital letters.

Authors: The list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.

Main text: A good abstract should address the five following questions in the relevant sections:

1. "Why did you start?" – Introduction or background / You should summarise, preferably in one sentence, the current knowledge specifically in relation to the work you are presenting.

2. "What did you try to do?" – Aims and objectives / State the aim of your study, and ideally include a short statement of the study's hypothesis. A legitimate scientific study is not done "to prove that something is true" but rather "to find out whether it is true." The distinction may seem small but it makes a significant difference. A formal hypothesis shows that you are objective.

3. "What did you do?" – Methods / In an abstract, the description of the methods has to be concise, and much of the details of what was done must be omitted. However, in a few short sentences, you can give the reader a good idea of the design of the study, the context in which it was done, and the types of patients or measurements that were included.

4. "What did you find?" – Results / It is important to give the main results of the study, not in subjective terms ("We found device X to be superior to device Y") but also in the form of some real data. You will need to choose which findings to report here: it should be the most important data in your study, and the findings on which your conclusions will be based. Do not include a table or figure unless you need it to show your results.

5. "What does it mean?" – Conclusions / Here, space constraints generally limit you to a single sentence of why you think your findings are important, and their potential implications. Keep your conclusions reasonable and supportable by the findings of your study. Remember that if your study was restricted to certain patients, or a particular therapy, or a specific device, its results may not extend beyond these restrictions.

Please see the full guidelines for more information

How long should an abstract be?

The maximum length of an abstract is 1,810 characters including characters and spaces in the following: Abstract Title, Abstract Body, Table, and Figures. N.B. if you insert a table, one character will be deducted per cell. If you insert an image/picture/figure, it will deduct 277 characters.

Can I include a table, graph or image in my abstract? If so, how?

Yes, you can include 2 figures and 2 tables. Please carefully follow the instructions on the online submission platform.
For tables, note that every cell of a table will count as 1 character: ie. a table of 2 columns and 3 lines will count as 6 characters. Then the content of each cell will be deducted normally. ie: if you enter the word "example" in a cell, it will count 7+1=8 characters

How many co-authors can I include on the authors list?

There is no limit regarding number of authors. However, the list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.

Notification and publication 

When will I be notified if my abstract submission has been successful?

Notification of either abstract acceptance or rejection for the ERS Congress in Milan 2017 will be sent to the abstract presenting author email address (the one used for submission) by the end of May, 2017.

I did not receive abstract notification of acceptance or rejection. Why?

Abstract notification will be sent to the email address that was used during abstract submission, therefore please check this email and/or the spam box.

My abstract has been accepted to the Congress. Do I have to prepare a paper version of the poster?

If your abstract is accepted in a Poster Discussion and / or a Thematic Poster session, you will have to print a paper poster. If you abstract is accepted to the Oral Presentation session the paper poster is not required; you will instead have to prepare a short presentation.

Is there any specific service where I can print the poster?

This information will be available after abstract acceptance notification.

When will the full abstract content be available, and where I can find it?

Full content of accepted abstracts will be visible in the online programme and and congress app from 2 September 2017 (the week prior the beginning of Congress). This date exclude only the abstract under embargo.

Where will my abstract be published?

Abstracts will be published in a supplement of the September 2017 edition of the European Respiratory Journal (ERJ).

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.

Changes and withdrawals

Abstract changes and withdrawals

After the notification of acceptance or rejection, you will be able to modify the list of authors until 1 week prior to the start of Congress, after which your abstract will be published online. To ensure all changes are considered please make sure the changes are done in due time, at least one month prior the Congress starts to ensure the abstract is updated on all platforms.
You will have to login to the abstract platform and edit the authors list or to change the presenting author.

Once submitted, can I still modify my abstract?

You cannot modify your abstract's body nor title after it is submitted.
After you receive the notification that your abstract is accepted to the ERS Congress (email will be sent by the end of May 2017) you will be able to modify the list of authors. You will have to login to the abstract platform and edit the authors list or to change the presenting author.

How can I change my abstract’s presenting author?

After you receive the notification that your abstract is accepted to the ERS Congress (email will be sent by the end of May 2017) you will be able to modify the list of authors.

You will have to login to the abstract platform and edit the authors list to change the presenting author.

How can I withdraw my abstract?

Once your abstract is accepted to the congress you need to contact the ERS office with the completed abstract withdrawal form (form will be available after abstract acceptance notification). Please contact us after you receive abstract notification email (end of May 2017) saying that you abstract has been accepted to the congress.

I submitted an abstract under the wrong category. Is it still possible to change it?

You cannot change the submission category. However, note that if the content would better fit another category, the organisers of the abstracts sessions might move your abstract into a different category.

Can I change the session of my abstract presentation?

No, the allocation of your abstract (schedule and presentation type) is decided by the International Congress Programme Committee and you will have no option to modify this.

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.

Grants and sponsorships

When will I be notified if my sponsorship / grant application has been successful?

You will receive notification if you have been selected by the end of July 2017.

Can I apply for sponsorship / a grant when submitting a late-breaking abstract?

No grant or sponsorship is offered for the late-breaking abstract submission.

If I change the presenting author of my abstract, will the new author receive the sponsorship / grant instead of me?

Yes, the person presenting and attending Congress will benefit from the grant or sponsorship. Note that we may need to cancel funding if the new presenting author is not eligible (for reasons such as age, etc).

If I will not be able to participate at Congress this year, would it be possible to transfer my sponsorship to next year’s Congress?

No, the grant or sponsorship is related to your abstract submitted and accepted for the ERS International Congress 2017 and not any other ERS event.

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.